-
Mashup Score: 0Bispecific Antibodies: Revolution in Oncology - 9 month(s) ago
KEY TAKEAWAYS Bispecific antibodies, such as talquetamab, represent a transformative shift in cancer treatment, offering the potential to target two antigens simultaneously and more effectively involve the immune system in the fight against cancer. Talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, ha…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Bispecifics antibodies: The next big thing in lymphoma treatment - 2 year(s) ago
Bispecific antibodies could make T-cell-engaging therapies more accessible to patients with lymphoma. Loretta Nastoupil, M.D., shares why these drugs could change immunotherapy for lymphoma, how they work, their side effect profile and exciting combination approaches.
Source: MD Anderson Cancer CenterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Combination approaches could improve efficacy of bispecific antibodies to treat lymphoma. Dr. Loretta Nastoupil explains what’s being explored: https://t.co/WmzSgeYQ2V @LNastoupilMD #BispecificAntibodies #EndCancer https://t.co/VFODQIxlpm
-
-
Mashup Score: 8Bispecifics target cancers’ most wanted - 3 year(s) ago
Two recent papers describe the development of bispecific antibodies that specifically target neoantigens derived from common oncogenic mutations.
Source: Nature Reviews CancerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NEW #ResearchHighlight! Two recent papers describe the development of #BispecificAntibodies that specifically target neoantigens derived from common oncogenic mutations. 📯https://t.co/dFFfeJsTZJ #RAS #TP53 @hopkinskimmel @natrescancer @JohnsHopkins https://t.co/Qzq4POE1S9
-
-
Mashup Score: 0The Multiple Myeloma Daily - 4 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Multiple Myeloma Daily! https://t.co/qkTPFfLrij Thanks to @theMMRF #multiplemyeloma #bispecificantibodies
-
-
Mashup Score: 1
Despite the introduction of novel agents such as proteasome inhibitors, immunomodulatory drugs, and autologous stem cell transplant, multiple myeloma (MM) largely remains an incurable disease. In recent years, monoclonal antibody-based treatment strategies have been developed to target specific surface antigens on MM cells. Treatment with bispecific antibodies (bsAbs) is an immunotherapeutic…
Source: MDPICategories: Hem/Oncs, Latest HeadlinesTweet-
Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma https://t.co/yQwOt9wPT1 @MDPIOpenAccess #bispecificantibodies
-
-
Mashup Score: 1The Future of Therapeutic Antibodies | Oxford Global - 4 year(s) ago
Please enter your details into the form below to access the content.
Source: Oxford GlobalCategories: Future of MedicineTweet-
The market for bispecific antibodies has seen a big growth in recent years - hear from John Delaney of @Amgen and what he thinks the future holds for therapeutic antibodies. https://t.co/IURLlEFW8y #bispecificantibodies #antibodies #therapeuticantibodies #amgen #Biologics20 https://t.co/jIYsERPKkk
-
We explore the power of bispecific #antibodies, spotlighting the promising therapy, Talquetamab, and its groundbreaking impact on multiple myeloma treatment. Plus, get insights from leading oncology expert, Dr. Carolina Schinke. #BispecificAntibodies https://t.co/cXWdHcYxlw https://t.co/YBRIej6ca3